Tanja Scherer

565 total citations
15 papers, 411 citations indexed

About

Tanja Scherer is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Tanja Scherer has authored 15 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Clinical Biochemistry and 6 papers in Physiology. Recurrent topics in Tanja Scherer's work include Metabolism and Genetic Disorders (11 papers), Mitochondrial Function and Pathology (7 papers) and Diet and metabolism studies (5 papers). Tanja Scherer is often cited by papers focused on Metabolism and Genetic Disorders (11 papers), Mitochondrial Function and Pathology (7 papers) and Diet and metabolism studies (5 papers). Tanja Scherer collaborates with scholars based in Switzerland, Norway and United States. Tanja Scherer's co-authors include Beat Thöny, Aurora Martı́nez, Ming Ying, Ángel L. Pey, Nunilo Cremades, Javier Sancho, Adrián Velázquez‐Campoy, Cary O. Harding, Shelley R. Winn and Ana Cristina Calvo and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Brain.

In The Last Decade

Tanja Scherer

15 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Scherer Switzerland 11 274 199 94 57 53 15 411
Vasily A. Aleshin Russia 12 153 0.6× 135 0.7× 84 0.9× 47 0.8× 158 3.0× 30 475
Claudine David France 10 457 1.7× 109 0.5× 89 0.9× 85 1.5× 16 0.3× 16 551
Viruna Neergheen United Kingdom 11 212 0.8× 61 0.3× 88 0.9× 62 1.1× 60 1.1× 11 391
Véronique Rüfenacht Switzerland 15 308 1.1× 285 1.4× 49 0.5× 34 0.6× 151 2.8× 35 545
Marjolein Bosma Netherlands 13 181 0.7× 138 0.7× 20 0.2× 42 0.7× 52 1.0× 18 377
Giulia Murtas Italy 13 282 1.0× 116 0.6× 60 0.6× 53 0.9× 300 5.7× 25 455
Gail A. M. Breen United States 17 467 1.7× 77 0.4× 163 1.7× 57 1.0× 32 0.6× 31 647
Masanori Itakura Japan 10 221 0.8× 37 0.2× 84 0.9× 31 0.5× 16 0.3× 20 379
Kikumaro Aoki Japan 13 361 1.3× 431 2.2× 182 1.9× 21 0.4× 97 1.8× 18 618
Marieke Hoeksma Netherlands 11 385 1.4× 551 2.8× 324 3.4× 20 0.4× 113 2.1× 14 654

Countries citing papers authored by Tanja Scherer

Since Specialization
Citations

This map shows the geographic impact of Tanja Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Scherer more than expected).

Fields of papers citing papers by Tanja Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Scherer. The network helps show where Tanja Scherer may publish in the future.

Co-authorship network of co-authors of Tanja Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Scherer. A scholar is included among the top collaborators of Tanja Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Scherer. Tanja Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Song, Zhuolun, Gabriella Allegri, Nicole Rimann, et al.. (2022). Intrabiliary infusion of naked DNA vectors targets periportal hepatocytes in mice. Molecular Therapy — Methods & Clinical Development. 27. 352–367. 2 indexed citations
2.
Winn, Shelley R., Sandra Dudley, Tanja Scherer, et al.. (2022). Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice. Molecular Genetics and Metabolism. 136(1). 46–64. 4 indexed citations
3.
Grisch‐Chan, Hiu Man, Ulrike Subotic, Nicole Rimann, et al.. (2022). Delivery of non-viral naked DNA vectors to liver in small weaned pigs by hydrodynamic retrograde intrabiliary injection. Molecular Therapy — Methods & Clinical Development. 24. 268–279. 7 indexed citations
4.
Shi, Tiejun, Ming Ying, Ann Kari Grindheim, et al.. (2021). The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase. Nature Communications. 12(1). 2073–2073. 19 indexed citations
5.
Allegri, Gabriella, Nicole Rimann, Benjamin Causton, et al.. (2019). Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age‐dependency of ammonia detoxification. Journal of Inherited Metabolic Disease. 42(6). 1064–1076. 7 indexed citations
6.
Himmelreich, Nastassja, Tiejun Shi, Tanja Scherer, et al.. (2019). Phenylalanine hydroxylase variants interact with the co‐chaperone DNAJC12. Human Mutation. 40(4). 483–494. 21 indexed citations
7.
Scherer, Tanja, Gabriella Allegri, Christineh N. Sarkissian, et al.. (2018). Tetrahydrobiopterin treatment reduces brain L‐Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice. Journal of Inherited Metabolic Disease. 41(4). 709–718. 10 indexed citations
8.
Grisch‐Chan, Hiu Man, Tanja Scherer, Gabriella Allegri, et al.. (2017). Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver Promoter. Molecular Therapy — Nucleic Acids. 7. 339–349. 19 indexed citations
9.
Winn, Shelley R., Tanja Scherer, Beat Thöny, et al.. (2017). Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice. Molecular Genetics and Metabolism. 123(1). 6–20. 40 indexed citations
10.
Winn, Shelley R., Tanja Scherer, Beat Thöny, & Cary O. Harding. (2015). High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU). Molecular Genetics and Metabolism. 117(1). 5–11. 27 indexed citations
11.
Noaín, Daniela, Ming Ying, Marte I. Flydal, et al.. (2015). Brain catecholamine depletion and motor impairment in aThknock-in mouse with type B tyrosine hydroxylase deficiency. Brain. 138(10). 2948–2963. 26 indexed citations
12.
Sarkissian, Christineh N., Ming Ying, Tanja Scherer, Beat Thöny, & Aurora Martı́nez. (2012). The mechanism of BH4-responsive hyperphenylalaninemia-As it occurs in the ENU1/2 genetic mouse model. Human Mutation. 33(10). 1464–1473. 12 indexed citations
13.
Calvo, Ana Cristina, Tanja Scherer, Ángel L. Pey, et al.. (2010). Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2. Journal of Neurochemistry. 114(3). 853–863. 32 indexed citations
14.
Thöny, Beat, Ana Cristina Calvo, Tanja Scherer, et al.. (2008). Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase. Journal of Neurochemistry. 106(2). 672–681. 49 indexed citations
15.
Pey, Ángel L., Ming Ying, Nunilo Cremades, et al.. (2008). Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. Journal of Clinical Investigation. 118(8). 2858–2867. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasily A. Aleshin Breakdown of academic impact, for papers by Claudine David Breakdown of academic impact, for papers by Viruna Neergheen Breakdown of academic impact, for papers by Véronique Rüfenacht Breakdown of academic impact, for papers by Marjolein Bosma Breakdown of academic impact, for papers by Giulia Murtas Breakdown of academic impact, for papers by Gail A. M. Breen Breakdown of academic impact, for papers by Masanori Itakura Breakdown of academic impact, for papers by Kikumaro Aoki Breakdown of academic impact, for papers by Marieke Hoeksma
Rankless by CCL
2026